Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LRRK2 Produits

(Leucine-Rich Repeat Kinase 2 (LRRK2))

Catégories

This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Catégories LRRK2 en vedette

LRRK2 Anticorps

High quality antibodies with extensive validation data.

LRRK2 recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Application WB, IHC, IF
Validations
  • (6)
N° du produit ABIN7531848
Quantité 20 μL
Fiche technique Fiche technique
Reactivity Human, Mouse
Application WB, IHC (p)
Validations
  • (1)
  • (3)
N° du produit ABIN391146
Quantité 400 μL
Fiche technique Fiche technique
Reactivity Human, Mouse
Application WB, IF
Validations
  • (2)
  • (3)
N° du produit ABIN391148
Quantité 400 μL
Fiche technique Fiche technique

LRRK2 recommandé Protéines

Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Source Escherichia coli (E. coli)
Validations
N° du produit ABIN7399454
Quantité 100 μg
Fiche technique Fiche technique
Reactivity Human
Source Escherichia coli (E. coli)
Validations
N° du produit ABIN7402172
Quantité 100 μg
Fiche technique Fiche technique
Reactivity Mouse
Source Escherichia coli (E. coli)
Validations
N° du produit ABIN7405774
Quantité 100 μg
Fiche technique Fiche technique

Dernières publications sur nos produits LRRK2

Bonello, Hassoun, Mouton-Liger, Shin, Muscat, Tesson, Lesage, Beart, Brice, Krupp, Corvol, Corti: "LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease." dans: Human molecular genetics, (2019) (PubMed).

Kim, Pajarillo, Rizor, Son, Lee, Aschner, Lee: "LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia." dans: PLoS ONE, Vol. 14, Issue 1, pp. e0210248, (2019) (PubMed).

Lim, Bang, Choi, Han, Kwon, Liu, Choi: "LRRK2 G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HT1A Receptor Upregulation in Mice." dans: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 38, Issue 7, pp. 1611-1621, (2019) (PubMed).

Hsieh, Li, Vanhauwaert, Nguyen, Davis, Bu, Wszolek, Wang: "Miro1 Marks Parkinson's Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson's Models." dans: Cell metabolism, Vol. 30, Issue 6, pp. 1131-1140.e7, (2019) (PubMed).

Takanashi, Funayama, Matsuura, Yoshino, Li, Tsuyama, Takashima, Nishioka, Hattori: "Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations." dans: Acta neuropathologica communications, Vol. 6, Issue 1, pp. 105, (2018) (PubMed).

Nucifora, Nucifora, Ng, Arbez, Guo, Roby, Shani, Engelender, Wei, Wang, Li, Moore, Pletnikova, Troncoso, Sawa, Dawson, Smith, Lim, Ross: "Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1." dans: Nature communications, Vol. 7, pp. 11792, (2016) (PubMed).

López de Maturana, Lang, Zubiarrain, Sousa, Vázquez, Gorostidi, Águila, López de Munain, Rodríguez, Sánchez-Pernaute: "Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons." dans: Journal of neuroinflammation, Vol. 13, Issue 1, pp. 295, (2016) (PubMed).

Bliederhaeuser, Zondler, Grozdanov, Ruf, Brenner, Melrose, Bauer, Ludolph, Gillardon, Kassubek, Weishaupt, Danzer: "LRRK2 contributes to monocyte dysregulation in Parkinson's disease." dans: Acta neuropathologica communications, Vol. 4, Issue 1, pp. 123, (2016) (PubMed).

Zhang, Li, Lu, Liu et al.: "Cerebral potential biomarkers discovery and metabolic pathways analysis of ?-synucleinopathies and the dual effects of Acanthopanax senticosus Harms on central nervous system through metabolomics ..." dans: Journal of ethnopharmacology, Vol. 163, pp. 264-72, (2015) (PubMed).

Reyniers, Del Giudice, Civiero, Belluzzi, Lobbestael, Beilina, Arrigoni, Derua, Waelkens, Li, Crosio, Iaccarino, Cookson, Baekelandt, Greggio, Taymans: "Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways." dans: Journal of neurochemistry, Vol. 131, Issue 2, pp. 239-50, (2015) (PubMed).

Synonymes et noms alternatifs relatifs à LRRK2

leucine-rich repeat kinase 2 (lrrk2), leucine rich repeat kinase 2 (LRRK2), leucine-rich repeat kinase 2 (Lrrk2), 4921513O20Rik, 9330188B09Rik, AURA17, AW561911, cI-46, D630001M17Rik, DARDARIN, Gm927, LRRK2, PARK8, RIPK7, ROCO2

Protein level used designations for LRRK2

  • leucine-rich repeat serine/threonine-protein kinase 2
  • leucine-rich repeat kinase 2
  • leucine-rich repeat serine/threonine-protein kinase 2-like
  • augmented in rheumatoid arthritis 17
Vous êtes ici:
Support technique